https://link.springer.com/article/10.1186/s13023-026-04351-0
This review by the IRDiRC Working Group on Medical Technologies for Rare Diseases examines the global regulatory landscape, current initiatives and patient engagement in orphan device development. It identifies remaining gaps and calls for greater regulatory harmonisation and stronger collaboration among stakeholders.
No hay comentarios:
Publicar un comentario